PEDIATRICS Vol. 39 No. 6 June 1967, pp. 838-843
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schotland, M. G.
Right arrow Articles by Grumbach, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schotland, M. G.
Right arrow Articles by Grumbach, M. M.

THE TOLBUTAMIDE TOLERANCE TEST IN THE EVALUATION OF CHILDHOOD HYPOGLYCEMIA

M. G. Schotland M.D.1, S. L. Kaplan M.D.1, and M. M. Grumbach M.D.1

1 Department of Pediatrics, Columbia University, College of Physicians and Surgeons, and Babies Hospital, New York, New York

The intravenous tolbutamide tolerance test has been evaluated in normal children and in children with ketotic hypoglycemia, idiopathic hypoglycemia, and the leucine-sensitive form of idiopathic hypoglycemia.

Following tolbutamide administration to normal children, the concentration of blood glucose falls 26% below fasting levels within 15 to 30 minutes and returns to fasting levels at the end of 2 hours. This is similar to the response of normal adults.

Some children with idiopathic hypoglycemia and with the leucine-sensitive form of idiopathic hypoglycemia have a prolonged hypoglycemic response to tolbutamide similar to that seen in patients with insulin secreting tumors.

The tolbutamide tolerance test in children appears to be of little help in differentiating islet cell adenoma from leucine-sensitive, ketotic, or idiopathic hypoglycemia.

Further evidence is presented that leucine and tolbutamide mediate insulin release from the pancreas by different mechanisms of action.

Submitted on May 18, 1966
Accepted on January 23, 1967